Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

CataloniaBio HealthTech Gala 2024

Events, News

Last night, Gate2Brain had the honor of attending the CataloniaBio HealthTech Gala with entrepreneurs, executives, investors, institutional representatives, and stakeholders gathered to celebrate the achievements in the health and life sciences sector in Catalonia.

It was an inspiring networking dinner aimed at fostering relationships and promoting business and scientific collaboration.

This year, the prestigious #BioExit award recognized two outstanding companies for their remarkable milestones in 2024:

AstraZeneca was honored for its significant commitment to Barcelona, demonstrated by the opening of its scientific innovation center just over a year ago. This center aims to accelerate the development of the next generation of treatments across five therapeutic fields.

WIVI vision was recognized for its remarkable internationalization efforts, particularly for entering the US market through a strategic agreement with a local partner. With a presence in 70 eye care centers in Spain and strategic partnerships with specialized firms, WIVI Vision is making waves in the industry.

We were proud to witness the growth and competitiveness of Catalonia’s health and life sciences sector. Mariona Serra-Pagès, President of #WeAreCataloniaBioHT, highlighted, “The association and our members work tirelessly to lead the development and implementation of major advances in health technologies and therapies, driving national competitiveness and cutting-edge healthcare.”

Thank you to everyone who made this extraordinary evening possible. It was a pleasure catching up with old friends and colleagues while making new connections!

March 12, 2024/by noticias
Tags: CataloniaBio HealthTech Gala 2024
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2024/03/Catalonia-Bio-Gala.png 380 520 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2024-03-12 18:10:382024-03-12 18:10:38CataloniaBio HealthTech Gala 2024

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
4YFN 2024Gate2Brain, winner of the Senén Vilaró Award, explains its innovative tec...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}